About This Webinar:
Schizophrenia and other severe mental illnesses have significant genetic components and thereby pass to new generations. Preventive treatments targeted to brain development before birth might decrease risk in the generation just being born. One new strategy uses a nutrient choline provided in the mother’s diet, similar to the worldwide use of folic acid to prevent spina bifida and cleft palate in newborns.
Click anywhere in the image below to play webinar recording.
Looking for the slides from this presentation? Download them here.
Robert R. Freedman, M.D.
Foundation Scientific Council Member
2015 Recipient of the Lieber Prize for Outstanding Achievement in Schizophrenia Research
NARSAD Grantee, 1999, 2006
Professor and Chairman, Department of Psychiatry
University of Colorado School of Medicine
Dr. Freedman's laboratory is concerned with understanding the development of schizophrenia. Using psychophysiological tools such as auditory evoked potentials with patients with schizophrenia and their families, his laboratory identifies individuals who may carry genes which convey risk for schizophrenia. Molecular biological tools such as gene sequencing and in situ hybridization are used to search for the genetic abnormalities in schizophrenia. Facilities range from a laboratory nursery school, where one can observe the development of children of mothers with schizophrenia, to basic science laboratories, where psychophysiological abnormalities can be modeled in animals and studied at the single neuron level.
Robert Freedman, MD, is a graduate of Harvard Medical School and trained at the National Institutes of Health and the University of Chicago.
Jeffrey Borenstein, M.D.
President & CEO, Brain & Behavior Research Foundation
Jeffrey Borenstein, M.D., joined the Brain & Behavior Research Foundation in 2012 as Chief Medical Officer and was appointed as President & Chief Executive Officer at the start of 2013. Dr. Borenstein has more than two decades of experience in health and non-profit leadership. He is former CEO/Medical Director of Holliswood Hospital, where he served from 1996 to 2012. He is a board-certified psychiatrist and the Host of the award-winning series, “Healthy Minds,” which is broadcast on public television stations across the United States. He is Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.
An active contributor to the psychiatric field for more than three decades, Dr. Borenstein currently chairs the Council on Communications of the American Psychiatric Association, the Mental Health Services Council of NY State, and the Section on Psychiatry, NY Academy of Medicine, where he is a Fellow. Among the many honors to his credit are the National Alliance on Mental Illness of NY State Connie Lieber Award, the American Psychiatric Association Special Presidential Commendation and the Federation of Organizations Community Mental Health Man of the Year Award.
Dr. Borenstein is Associate Clinical Professor of Psychiatry, Columbia University College of Physicians & Surgeons. He is a graduate of Harvard College and New York University School of Medicine.